Prospera Financial Services’s Corcept Therapeutics CORT Stock Holding History

Prospera Financial Services’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$461K	Buy	+5,687	New	+$612K	0.01%	1095

Other funds holding CORT

Parallel Advisors San Francisco, California $7.42B AUM 27.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.45B AUM 70.46% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Boston Trust Walden Boston, Massachusetts $12.4B AUM 21.62% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Prospera Financial Services's CORT Position: Q3 2026 in Review

Prospera Financial Services opened a new position in Corcept Therapeutics (CORT) in Q3 2026: 5,687 shares worth $461K. The stake represents 0.01% of the portfolio and ranks #1095 among its holdings.

228 funds tracked by Wall St. Rank hold CORT as of Q3 2026.

Prospera Financial Services held 5,687 shares of Corcept Therapeutics worth $461K as of Q3 2026.
Corcept Therapeutics was a new Prospera Financial Services position in Q3 2026.
Corcept Therapeutics made up 0.01% of Prospera Financial Services's portfolio in Q3 2026, its #1095 holding.
228 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.

Based on Prospera Financial Services's 13F filing for Q3 2026, filed 4 Nov 2026.